WeVote
Log In

Bill

Bill

HB 4036

bulk drug substances; prohibitions

57th Legislature - Second Regular Session Introduced by Michele Peña

Arizona bill prohibits unlicensed manufacture and distribution of bulk pharmaceutical ingredients to prevent drug diversion and unsafe compounding.

FAILED
0
WeVote Research Nonpartisan
Bill Summary · HB 4036

Legislative bill overview

HB 4036 would prohibit the manufacture, distribution, and possession of bulk drug substances in Arizona without proper licensing and oversight. The bill appears designed to regulate raw pharmaceutical ingredients and precursor chemicals that could be diverted for illegal drug production or unsafe compounding practices.

Why is this important

Bulk drug substances are legitimate pharmaceutical ingredients used by licensed manufacturers and compounders, but unregulated access creates risks for counterfeit medications, contaminated drugs, and illicit drug manufacturing. Establishing clear regulatory frameworks affects the pharmaceutical supply chain, legitimate compounding pharmacies, and law enforcement's ability to prevent drug diversion.

Potential points of contention

  • Impact on legitimate compounding pharmacies - Strict regulations could increase costs or create compliance burdens for licensed compounders who lawfully use bulk substances to create customized medications for patients
  • Definition and scope ambiguity - The bill's definition of "bulk drug substances" could be overly broad or unclear, potentially capturing materials that shouldn't require licensing
  • Small business and manufacturing concerns - Licensing requirements may disproportionately affect smaller pharmaceutical manufacturers or research facilities compared to large corporations

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.